Prevalence, Severity, and Comorbidity of 12-Month DSM-IV Disorders in the National Comorbidity Survey Replication
TLDR
Although mental disorders are widespread, serious cases are concentrated among a relatively small proportion of cases with high comorbidity, as shown in the recently completed US National Comorbidities Survey Replication.Abstract:
Background Little is known about the general population prevalence or severity of DSM-IV mental disorders. Objective To estimate 12-month prevalence, severity, and comorbidity of DSM-IV anxiety, mood, impulse control, and substance disorders in the recently completed US National Comorbidity Survey Replication. Design and Setting Nationally representative face-to-face household survey conducted between February 2001 and April 2003 using a fully structured diagnostic interview, the World Health Organization World Mental Health Survey Initiative version of the Composite International Diagnostic Interview. Participants Nine thousand two hundred eighty-two English-speaking respondents 18 years and older. Main Outcome Measures Twelve-month DSM-IV disorders. Results Twelve-month prevalence estimates were anxiety, 18.1%; mood, 9.5%; impulse control, 8.9%; substance, 3.8%; and any disorder, 26.2%. Of 12-month cases, 22.3% were classified as serious; 37.3%, moderate; and 40.4%, mild. Fifty-five percent carried only a single diagnosis; 22%, 2 diagnoses; and 23%, 3 or more diagnoses. Latent class analysis detected 7 multivariate disorder classes, including 3 highly comorbid classes representing 7% of the population. Conclusion Although mental disorders are widespread, serious cases are concentrated among a relatively small proportion of cases with high comorbidity.read more
Citations
More filters
Journal ArticleDOI
Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication
Ronald C. Kessler,Patricia A. Berglund,Olga Demler,Robert Jin,Kathleen R. Merikangas,Ellen E. Walters +5 more
TL;DR: Lifetime prevalence estimates are higher in recent cohorts than in earlier cohorts and have fairly stable intercohort differences across the life course that vary in substantively plausible ways among sociodemographic subgroups.
Journal ArticleDOI
2016 Alzheimer's disease facts and figures
Journal ArticleDOI
Prevalence, Correlates, Disability, and Comorbidity of DSM-IV Alcohol Abuse and Dependence in the United States: Results From the National Epidemiologic Survey on Alcohol and Related Conditions
TL;DR: Comorbidity of alcohol dependence with other substance disorders appears due in part to unique factors underlying etiology for each pair of disorders studied while comorbidities of alcohol addiction with mood, anxiety, and personality disorders appears more attributable to factors shared among these other disorders.
Journal ArticleDOI
Validation and Standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the General Population
Bernd Löwe,Oliver Decker,Stefanie Müller,Elmar Brähler,Dieter Schellberg,Wolfgang Herzog,Philipp Yorck Herzberg +6 more
TL;DR: Evidence supports reliability and validity of the G AD-7 as a measure of anxiety in the general population and can be used to compare a subject's GAD-7 score with those determined from a general population reference group.
Journal ArticleDOI
Twelve-Month Use of Mental Health Services in the United States Results From the National Comorbidity Survey Replication
Philip S. Wang,Michael Lane,Mark Olfson,Harold Alan Pincus,Kenneth B. Wells,Ronald C. Kessler +5 more
TL;DR: Most people with mental disorders in the United States remain either untreated or poorly treated, and interventions are needed to enhance treatment initiation and quality.
References
More filters
Journal ArticleDOI
Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication
Ronald C. Kessler,Patricia A. Berglund,Olga Demler,Robert Jin,Kathleen R. Merikangas,Ellen E. Walters +5 more
TL;DR: Lifetime prevalence estimates are higher in recent cohorts than in earlier cohorts and have fairly stable intercohort differences across the life course that vary in substantively plausible ways among sociodemographic subgroups.
Journal ArticleDOI
Lifetime and 12-Month Prevalence of DSM-III-R Psychiatric Disorders in the United States: Results From the National Comorbidity Survey
Ronald C. Kessler,Katherine A. McGonagle,Shanyang Zhao,Christopher B. Nelson,Michael R. Hughes,Suzann Eshleman,Hans-Ulrich Wittchen,Kenneth S. Kendler +7 more
TL;DR: The prevalence of psychiatric disorders is greater than previously thought to be the case, and morbidity is more highly concentrated than previously recognized in roughly one sixth of the population who have a history of three or more comorbid disorders.
Journal ArticleDOI
The World Mental Health (WMH) Survey Initiative Version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI).
TL;DR: An overview of the World Mental Health Survey Initiative version of the WHO Composite International Diagnostic Interview (CIDI) is presented and a discussion of the methodological research on which the development of the instrument was based is discussed.
Journal ArticleDOI
Prevalence and Development of Psychiatric Disorders in Childhood and Adolescence
TL;DR: The risk of having at least 1 psychiatric disorder by age 16 years is much higher than point estimates would suggest and concurrent comorbidity and homotypic and heterotypic continuity are more marked in girls than in boys.
Journal ArticleDOI
Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys.
Koen Demyttenaere,Ronny Bruffaerts,Jose Posada-Villa,Isabelle Gasquet,Kovess,J P Lépine,Matthias C. Angermeyer,Sebastian Bernert,de Girolamo G,Pierluigi Morosini,G Polidori,Takehiko Kikkawa,Norito Kawakami,Y. Ono,Tadashi Takeshima,Hidenori Uda,Elie G. Karam,John Fayyad,A. N. Karam,Zeina Mneimneh,María Elena Medina-Mora,Guilherme Borges,Carmen Lara,de Graaf R,Johan Ormel,Oye Gureje,Shen Y,Y. Huang,Zhang M,Jordi Alonso,Josep Maria Haro,Gemma Vilagut,Evelyn J. Bromet,Semyon Gluzman,C. P. M. Webb,Ronald C. Kessler,Kathleen R. Merikangas,James C. Anthony,Von Korff Mr,Philip S. Wang,Traolach S. Brugha,Sergio Aguilar-Gaxiola,Sing Lee,Steven G. Heeringa,B. E. Pennell,Alan M. Zaslavsky,T. B. Üstün,Somnath Chatterji +47 more
TL;DR: Reallocation of treatment resources could substantially decrease the problem of unmet need for treatment of mental disorders among serious cases and careful consideration needs to be given to the value of treating some mild cases, especially those at risk for progressing to more serious disorders.